期刊信息/Journal information
脑出血（英文）/Journal Brain Hemorrhages
收录年代
Clazosentan,first approval in Japan:Has perioperative management of subarachnoid hemorrhage changed
Hidenori Suzuki1-2
Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022:The impact of clazosentan and treatment modalities on outcomes
Hajime Maeda;Tsuyoshi Izumo;Kazuaki Okamura;Susumu Yamaguchi;Yoichi Morofuji;Takayuki Matsuo3-9
Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage
Hidenori Suzuki;Hirofumi Nishikawa;Masashi Fujimoto;Naoki Toma;Hideki Nakajima;Tomonori Ichikawa;Ryuta Yasuda;Takeshi Okada;Fuki Goto;Shota Ito;Yasutaka Horiuchi;Yotaro Kitano10-16
Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm
Takaaki Itazu;Kiyofumi Yamada;Hirotoshi Imamura;Hisae Mori;Koji Iihara;Hiroharu Kataoka;Taichi Ikedo;Takeyoshi Tsutsui;Akihiro Niwa;Yuji Kushi;Saya Ozaki;Naoto Yamada;Koji Shimonaga;Eika Hamano17-21
Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan:A case series
Yosuke Akamatsu;Hiroshi Kashimura;Yoshitaka Kubo;Kuniaki Ogasawara;Kohei Chida;Kenya Miyoshi;Daigo Kojima;Jun-Ichi Nomura;Kengo Setta;Takayuki Chiba;Takahiro Koji;Shunrou Fujiwara22-26
Initial results of clazosentan with multiple-drug management for the prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
Tatsuki Kimura;Kaima Suzuki;Hiroki Sato;Aoto Shibata;Yushiro Take;Hidetoshi Ooigawa;Masataka Yoshimura;Shinya Kohyama;Hiroki Kurita27-32
A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage
Rikuo Nishii;Kunimasa Teranishi;Kota Nakajima;Yuji Naramoto;Yasuhiro Yamamoto;Satohiro Kawade;Ryo Sakisuka;Takateru Takamatsu;Masanori Tokuda;Hikari Tomita;Mai Yoshimoto;Tsuyoshi Ohta;Nobuyuki Sakai;Nobuyuki Fukui;Masaomi Koyanagi;Masanori Goto;Junichi Takeda;Ryu Fukumitsu;Tadashi Sunohara;Yuki Takano33-38
Could clazosentan,first approved in Japan,improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management
Eiji Shikata;Yasuhisa Kanematsu;Yasushi Takagi;Izumi Yamaguchi;Masaaki Korai;Takeshi Miyamoto;Tadashi Yamaguchi;Hiroshi Kagusa;Kenji Shimada;Yoshiteru Tada;Keiko T.Kitazato39-45
征稿启事
后插1-后插4